Bookmark
Forward
Ozanimod (Zeposia) for multiple sclerosis.
The Medical letter on drugs and therapeutics 2020 Aug 24
Sizes of these terms reflect their relevance to your search.
No abstract available.
Citation
Ozanimod (Zeposia) for multiple sclerosis.
The Medical letter on drugs and therapeutics.
2020 Aug 24;62(1605):132-134
Mesh Tags
Administration, Oral
Clinical Trials as Topic
Humans
Indans
Multiple Sclerosis
Multiple Sclerosis, Relapsing-Remitting
Oxadiazoles
Sphingosine 1 Phosphate Receptor Modulators
Substances
Indans
Oxadiazoles
Sphingosine 1 Phosphate Receptor Modulators
ozanimod
PMID: 32970043
View Full Text